Abstract | BACKGROUND: Increasing evidence indicates that lipophilic and/or protein-bound substances such as p-cresol are responsible for adverse physiological alterations in uraemic patients. To better understand the evolution of p-cresol disposition in renal failure and dialysis patients, it is necessary to determine its kinetic characteristics and biotransformation pathways. METHODS: We studied the biotransformation of p-cresol after intravenous injection of the compound in eight rats with normal renal function. Urine was collected in four 1 h intervals. To evaluate the presence of p-cresol metabolites, beta-glucuronidase was added to urine samples and the isolated unidentified chromatographic peak observed in previous experiments was submitted to tandem mass spectrometry (MS/MS) analysis. RESULTS: Administration of p-cresol produced a p-cresol peak and an unknown peak, suggesting biotransformation of the compound. Addition of beta-glucuronidase to urine samples and incubation at 37 degrees C resulted in a marked decrease in the unidentified peak height (P<0.001) together with an increase in p-cresol peak height (P<0.001), suggesting that the unidentified peak was composed, at least in part, of p-cresylglucuronide. Mass spectrometry (MS) and MS/MS analysis of the isolated unidentified peak confirmed the presence of p-cresylglucuronide. Linear regression between the peak height of p-cresylglucuronide before enzyme treatment and the increase in p-cresol peak height after enzyme treatment in samples incubated with beta-glucuronidase allowed us to calculate the amount of p-cresylglucuronide as its p-cresol equivalents. This revealed that 64% of the injected p-cresol was excreted as glucuronide. There was no change in peak heights when sulphatase was added to the urine. When p-cresol and p-cresylglucuronide levels were combined, approximately 85% of all administered p-cresol was recovered in the urine. In addition, the combined urinary excretion of p-cresol and p-cresylglucuronide was more than four times greater than excretion of p-cresol by itself (P<0.01). CONCLUSIONS:
|
Authors | Gerrit Lesaffer, Rita De Smet, Frans M Belpaire, Bruno Van Vlem, Marijn Van Hulle, Rita Cornelis, Norbert Lameire, Raymond Vanholder |
Journal | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
(Nephrol Dial Transplant)
Vol. 18
Issue 7
Pg. 1299-306
(Jul 2003)
ISSN: 0931-0509 [Print] England |
PMID | 12808165
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cresols
- Glucuronides
- Toxins, Biological
- 4-cresol
|
Topics |
- Animals
- Biotransformation
- Chromatography, High Pressure Liquid
- Cresols
(metabolism, pharmacokinetics, urine)
- Disease Models, Animal
- Glucuronides
(metabolism, pharmacokinetics, urine)
- Male
- Mass Spectrometry
- Rats
- Time Factors
- Toxins, Biological
(metabolism, pharmacokinetics, urine)
- Uremia
(metabolism, urine)
|